Momelotinib reduces transfusion requirements in patients with myelofibrosis
Ruben A. Mesa, Stephen T. Oh, Aaron T. Gerds, Vikas Gupta, John Catalano, Francisco Cervantes, Timothy Devos, Marek Hus, Jean‐Jacques Kiladjian, Ewa Lech‐Marańda, Donal P. McLornan, Jeanne Palmer, Uwe Platzbecker, Jacek Treliński, Kazuya Shimoda, Rafe Donahue, Koenraad D’Hollander, Mark Kowalski, Srđan Verstovšek
Abstract
sponsorship: This work was funded by Sierra Oncology, Inc. (Sierra Oncology, Inc., Grants-in-Aid for Scientific Research|20H03713)
Topics & Concepts
MyelofibrosisMedicineBlood transfusionIntensive care medicineHematologic NeoplasmsInternal medicineCancerBone marrowMyeloproliferative Neoplasms: Diagnosis and TreatmentChronic Myeloid Leukemia TreatmentsKruppel-like factors research